CD16 抗体
Quick Overview for CD16 抗体 (ABIN2478680)
抗原
See all CD16 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            交叉反应
- 猫
- 
                                            产品特性
- Purified IgG
- 
                                            纯化方法
- Purified
- 
                                            免疫原
- Human neutrophils
- 
                                            亚型
- IgG2b
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1.0 mg/mL
 
- 
                                            
- 
    - 
                                            : "Natural killer cells: frequency, phenotype and function in healthy cats."    in: Veterinary immunology and immunopathology, Vol. 150, Issue 1-2, pp. 69-78, (2012)         (PubMed).        
 : "Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity." in: Immunology, Vol. 110, Issue 3, pp. 335-40, (2003) (PubMed).
 
 
- 
                                            : "Natural killer cells: frequency, phenotype and function in healthy cats."    in: Veterinary immunology and immunopathology, Vol. 150, Issue 1-2, pp. 69-78, (2012)         (PubMed).        
- 
    - CD16
- 
                                            别名
- CD16
- 
                                            背景
- Synonyms: FcRIII
- 
                                            基因ID
- 2214, 2215
- 
                                            UniProt
- O75015, P08637
- 
                                            途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
 抗原
- 
                    
 
                                     
                                     
                                    